Is the price fair?
What AVNT's price assumes
Avient Corporation trades at 26.0× earnings against 28.3× for the median Specialty Chemicals name, cheaper than its own group.
26.0
Trailing P/E · Specialty Chemicals median 28.3 · cheaper than the typical name in its group
- Price / sales
- 1.01
Price / sales · as of 2026-Q1
- Free cash flow yield
- 5.9%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- +3.4%
Growth the price implies · The price pays for +3.4% free cash flow growth a year for a decade; the business has delivered −5.7% a year over the last three.
Details›
- Price / book2026-Q1
- 1.38
- EV / EBIT2026-Q1
- 16.1
- EV / sales2026-Q1
- 1.47
- Basic Materials median P/E153 names
- 22.8
- Specialty Chemicals median P/E37 names
- 28.3
- Free cash flow, trailing twelve months
- $205M
- Market capitalisation
- $3.45B
- 3-year revenue growth
- −0.70%
- 3-year free cash flow growth
- −5.7%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $23.83 |
| Its own P/E history, median | $28.00 |
| Its own P/E history, upper quartile | $45.54 |
| 52-week range | $26.82 – $46.35 |
| Today | $44.79 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #14 of 36 by Smart Score